Zevra Therapeutics, Inc. (ZVRA) PT Lowered to $22 at Roth/MKM
Tweet Send to a Friend
Roth/MKM analyst Jonathan Aschoff lowered ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
